← All Sponsors
SPONSOR

UMC Utrecht

Total Trials
6
Recruiting
6
Phases
Phase 3

UMC Utrecht is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Sensorineural Hearing Loss, Transposition of Great Vessels, Tetralogy of Fallot, Truncus Arteriosus.

The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — UMC Utrecht

How many clinical trials has UMC Utrecht sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by UMC Utrecht, of which 6 are actively recruiting participants. These trials cover conditions including Sensorineural Hearing Loss, Transposition of Great Vessels, Tetralogy of Fallot. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does UMC Utrecht research focus on?
UMC Utrecht clinical trials span Sensorineural Hearing Loss, Transposition of Great Vessels, Tetralogy of Fallot, Truncus Arteriosus, Pulmonary Artery Stenosis Supravalvular Congenital, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a UMC Utrecht clinical trial?
To participate in a UMC Utrecht trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all UMC Utrecht trials with current recruitment status updated daily.

Clinical Trials by UMC Utrecht

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology